Boston, MA, US.
Vertex Pharmaceuticals is seeking a Director, Hemoglobinopathies, to join the North America Health Economics & Outcomes Research (HEOR) team to develop and execute on the HEOR strategy and related tactics to support the commercialization of CASGEVY (exagamglogene autotemcel [exa-cel]) for sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT) in the United States (US) and Canada. This person will work in a highly cross-functional matrix team environment, serving as the North America HEOR lead for CASGEVY and interfacing with Market Access, Public Affairs, as well as Medical teams, to develop and execute on a seamless plan for communicating the holistic value of CASGEVY throughout its product lifecycle to various stakeholders including payers and policymakers. This person is expected to exhibit a strong sense of urgency to achieve corporate objectives while maintaining the highest ethical, regulatory and scientific standards. This position reports to the Head of North America HEOR.
Key Responsibilities:
- Represent HEOR at US and Canadian cross-functional teams
- Develop and execute on a cross-functionally aligned HEOR plan for CASGEVY in both SCD and TDT indications in the US both pre- and peri-launch.
- Identify and execute innovative HEOR solutions that are necessary to support access and reimbursement of CASGEVY in the US and Canada.
- Develop external customer-facing value demonstration tools that meet regulatory standards and train and certify appropriate field teams (e.g., field HEOR, payer team) for effective delivery
- Work closely with global HEOR team to inform evidence generation and publication plans from the US and Canadian perspective and to ensure timely translation of HEOR studies for external value communication to customers
- Occasionally engage directly with external customers (e.g., payer accounts, health systems, policymakers) to discuss HEOR data and represent Vertex as needed to achieve business objectives
- Lead and execute collaborative research with US and Canadian external customer entities (e.g., payers, health systems) in a compliant manner
Minimum Qualifications
- Advanced degree (e.g. PhD, MD, MPH, or PharmD) in a scientific discipline. A clinical degree must be supplemented with advanced training in a HEOR-related discipline (e.g., MPH/MS, PhD, HEOR fellowship).
- Minimum of 10 years of combined experience in health economics and outcomes research, with at least 5 years of pharmaceutical industry experience.
- US Market experience required. A gene/cell therapy experience is a plus.
- Demonstrated capabilities in interpreting and applying the 2018 FDA Payor Guidance to payer communication in the US
- Robust understanding of the HTA process and methodology; hands-on experience with HTA dossier submission and review is preferred.
- A track record of peer-reviewed publications demonstrating experience in COAs, observational research, and/or health economic modeling
- Strong communication skills, both verbal and written, including the ability to effectively present to both internal and external audiences
- Results oriented and excellent analytic and project management skills
- A strong sense of urgency and commitment to patients
#LI-KM3
Flex Designation:Hybrid-Eligible Or On-Site Eligible
Flex Eligibility Status:
In this Hybrid-Eligible role, you can choose to be designated as:
1. Hybrid: work remotely up to two days per week; or select
2. On-Site: work five days per week on-site with ad hoc flexibility.
Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.
This job ad will be unpublished on 08/02/2025.
This job is posted by Vertex.
This link brings you to the website of Vertex.
Please mention that you found the role via EuropeanHealthEconomics.com. Thank you and good luck!
